Botox Owner Allergan to Buy Maker of Double-Chin Treatment

Botox maker Allergan agreed to buy Kythera Biopharmaceuticals, which is preparing to launch an injection aimed at reducing so-called double chins, for about $2.1 billion.

from WSJ.com: US Business http://ift.tt/1fgExyL
via IFTTT